SureTrader
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

I think it's important to remember that the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BlackDoggie Member Profile
 
Followed By 9
Posts 542
Boards Moderated 0
Alias Born 02/17/17
160x600 placeholder
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 4:42:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 4:39:35 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 6:33:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 6:33:16 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:02:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/14/2018 12:22:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2018 4:38:32 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/7/2018 4:53:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2018 4:34:05 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/31/2018 4:43:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 4:38:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2018 4:34:56 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/25/2018 4:35:52 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/23/2018 8:14:51 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/23/2018 8:03:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2018 7:51:29 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/10/2018 5:01:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2018 4:56:01 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/8/2018 4:37:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/8/2018 4:36:15 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 12/29/2017 5:18:12 PM
BlackDoggie   Friday, 11/10/17 10:12:17 AM
Re: BlueHorseshoe13 post# 18091
Post # of 20338 
I think it's important to remember that the data was still blinded - even the FDA couldn't see the data on 10/12. This line of reasoning is off base at face value.

Now, why the FDA required additional patients is still an interesting question. I have a completely unsubstantiated theory based on the rejected ODD application, but it has nothing to do with data.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist